Italy is positioning itself to become a major global hub for gene therapy and advanced medical research, leveraging growing scientific capacity, strategic investments and collaboration between public institutions and private companies.
Over the past decade, the country has significantly expanded its efforts in gene therapy, RNA-based treatments and precision medicine, fostering a network of research centers and biotech firms that are increasingly drawing attention from international investors and partners.
